Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a …

BS Wiggins, JJ Saseen, RL Page, BN Reed, K Sneed… - Circulation, 2016 - Am Heart Assoc
A n D GUID eLIneS affordability may often dictate which medications may be prescribed.
Patients who have exhausted prescription drug coverage or who are uninsured may require …

Impact of OATP transporters on pharmacokinetics

A Kalliokoski, M Niemi - British journal of pharmacology, 2009 - Wiley Online Library
Membrane transporters are now recognized as important determinants of the
transmembrane passage of drugs. Organic anion transporting polypeptides (OATP) form a …

Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake

M Niemi, MK Pasanen, PJ Neuvonen - Pharmacological reviews, 2011 - ASPET
The importance of membrane transporters for drug pharmacokinetics has been increasingly
recognized during the last decade. Organic anion transporting polypeptide 1B1 (OATP1B1) …

Drug interactions with lipid‐lowering drugs: mechanisms and clinical relevance

PJ Neuvonen, M Niemi… - Clinical Pharmacology & …, 2006 - Wiley Online Library
Lipid‐lowering drugs, especially 3‐hydroxy‐3‐methylglutaryl–coenzyme A inhibitors
(statins), are widely used in the treatment and prevention of atherosclerotic disease. The …

Inhibition and induction of human cytochrome P450 enzymes: current status

O Pelkonen, M Turpeinen, J Hakkola, P Honkakoski… - Archives of …, 2008 - Springer
Variability of drug metabolism, especially that of the most important phase I enzymes or
cytochrome P450 (CYP) enzymes, is an important complicating factor in many areas of …

Narrative review: statin-related myopathy

TR Joy, RA Hegele - Annals of internal medicine, 2009 - acpjournals.org
Statin-related myopathy is a clinically important cause of statin intolerance and
discontinuation. The spectrum of statin-related myopathy ranges from common but clinically …

Role of cytochrome P450 2C8 in drug metabolism and interactions

JT Backman, AM Filppula, M Niemi… - Pharmacological reviews, 2016 - ASPET
During the last 10-15 years, cytochrome P450 (CYP) 2C8 has emerged as an important drug-
metabolizing enzyme. CYP2C8 is highly expressed in human liver and is known to …

Statin-induced myopathy: a review and update

TT Abd, TA Jacobson - Expert opinion on drug safety, 2011 - Taylor & Francis
Introduction: Statin-induced myopathy is an important cause of statin intolerance and the
most common cause of statin discontinuation. Observational studies estimate that 10–15 …

Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics

RH Ho, RG Tirona, BF Leake, H Glaeser, W Lee… - Gastroenterology, 2006 - Elsevier
Background & Aims The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase
inhibitors, or statins, target liver HMG-CoA and are of proven benefit in the prevention of …

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia

JC Fruchart, F Sacks, MP Hermans, G Assmann… - The American journal of …, 2008 - Elsevier
Despite achieving targets for low-density lipoprotein (LDL) cholesterol, blood pressure, and
glycemia in accordance with current standards of care, patients with dyslipidemia remain at …